Structure (Otrexup 01)
Otrexup Injection, Solution
Product Images NDC 54436-025
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Otrexup (NDC 54436-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Antares Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Antares Pharma Logo (Otrexup 02)
Antares Pharma Logo (Otrexup 03)
Ifu Figure A (Otrexup 04)
This is a set of instructions for using Otrexup, which is a medical device that appears to include a needle, a safety clip, and a window marked with the number 2. The instructions specify that the device has a safety clip and labeling on both the needle end and the opposite end. There is a diagram included in Figure A.*
Ifu Figure B (Otrexup 05)
Ifu Figure C (Otrexup 06)
Ifu Figure D (Otrexup 07)
Ifu Figure E (Otrexup 08)
Ifu Figure F (Otrexup 09)
Ifu Figure G (Otrexup 10)
The text is a label or title of a medical image, which shows the abdomen of a person. It is not possible to provide additional information based on this limited text.*
Ifu Figure H (Otrexup 11)
The given text describes a viewing window that is partially blocked with a red flag. The window is observed before the dose is delivered and half-blocked after the full dose is given. Additionally, a figure "H" is referenced. It is likely that this information relates to a medical device or equipment used to administer doses.*
10 mg Label (Otrexup 13)
This appears to be instructions on how to administer Otrexup, a medication called methotrexate, using an injection device that delivers the medicine subcutaneously (under the skin). The device should be used on the thigh or abdomen after ensuring it is firmly pressed, and one would hear a click indicating the medication has been delivered. The text includes information on the lot number and expiration date of the medication.*
12.5 mg Label (Otrexup 14)
Description: This is a medication label for Otrexup, generic name methotrexate. The medication is used for subcutaneous injection, for the treatment of adult patients with severe active rheumatoid arthritis. The label contains instructions on how to administer the medication and dosage information. The medication should not be used on the thigh or abdomen, and it should be kept at room temperature.*
15 mg Label (Otrexup 15)
This appears to be a label or packaging information for a medication named "methotrexate". It provides an NDC number and instructions for use, including caution to place the needle end flat and push the device firmly. It also indicates the substance is for "subcutaneous" use and has a specific lot and expiration date. The window on the packaging should not be blocked if stored in a controlled room temperature.*
17.5 mg Label (Otrexup 16)
This appears to be a label for a medication called methotrexate, made by a company called Antares Pharma. The medication is meant for subcutaneous injection and is used for some medical purpose. Other details on dosage and usage instructions are present on the label.*
20 mg Label (Otrexup 17)
NDC# 54436-L Otrexup is a prescription medicine that contains methotrexate and is used for subcutaneous injections. It is important not to use if the tab across the cap is broken. The packaging includes a lot number and an expiration date. The remaining text is not available.*
22.5 mg Label (Otrexup 18)
Otrexup is a medication for subcutaneous use containing methotrexate. It comes in a small device that should not be used if the tab is broken before fully depressed. After applying the device, hold it for three seconds while counting to three, then remove it. There is a window to check the lot and expiration date, marked with a number "3602202".*
25 mg Label (Otrexup 19)
10 mg 4-pack Carton Label (Otrexup 21)
Otrexup is a medication available only for subcutaneous injection. It is used once a week. This medication comes in the form of 4 single-dose injections containing 10mg/0 4mL of methotrexate. The injection contains sodium chloride and water for injection, and the pH is adjusted using hydrochloric acid and sodium hycroride. Otrexup is manufactured by Antares Pharmanc, Ewing, N 08528. The text also contains identification numbers and temperature storage instructions.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
